EDGAR Filing Documents for 0001437749-17-011116

Form 8-K - Current report:

SEC Accession No. 0001437749-17-011116

Filing Date

2017-06-12

Accepted

2017-06-12 07:32:28

Documents

Period of Report

2017-06-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	plxp20170611_8k.htm	8-K	36976
2	EXHIBIT 4.1	ex4-1.htm	EX-4.1	101026
3	EXHIBIT 5.1	ex5-1.htm	EX-5.1	13012
4	EXHIBIT 10.1	ex10-1.htm	EX-10.1	168057
5	EXHIBIT 10.2	ex10-2.htm	EX-10.2	18013
6	EXHIBIT 10.3	ex10-3.htm	EX-10.3	15428
7	EXHIBIT 99.1	ex99-1.htm	EX-99.1	12961
8	EXHIBIT 99.2	ex99-2.htm	EX-99.2	113162
9	EXHIBIT 99.3	ex99-3.htm	EX-99.3	248940
10		plx.jpg	GRAPHIC	3134
11		jwllp2.jpg	GRAPHIC	7939
	Complete submission text file	0001437749-17-011116.txt		744519

Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054

Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249

PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)